Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023

SELL
$31.15 - $33.39 $1,339 - $1,435
-43 Reduced 0.58%
7,397 $245,000
Q3 2022

Nov 16, 2022

SELL
$30.9 - $33.55 $13,657 - $14,829
-442 Reduced 5.61%
7,440 $235,000
Q2 2022

Aug 16, 2022

BUY
$23.75 - $31.69 $2,375 - $3,169
100 Added 1.29%
7,882 $240,000
Q1 2022

May 16, 2022

BUY
$19.97 - $26.94 $29,855 - $40,275
1,495 Added 23.78%
7,782 $202,000
Q4 2021

Feb 14, 2022

SELL
$17.46 - $21.61 $4,033 - $4,991
-231 Reduced 3.54%
6,287 $128,000
Q3 2021

Nov 16, 2021

SELL
$17.35 - $22.5 $9,316 - $12,082
-537 Reduced 7.61%
6,518 $125,000
Q2 2021

Aug 16, 2021

BUY
$18.01 - $28.32 $7,005 - $11,016
389 Added 5.84%
7,055 $156,000
Q1 2021

May 17, 2021

BUY
$19.76 - $29.89 $95,164 - $143,950
4,816 Added 260.32%
6,666 $175,000
Q4 2020

Feb 16, 2021

BUY
$15.73 - $21.66 $1,258 - $1,732
80 Added 4.52%
1,850 $35,000
Q2 2020

Aug 14, 2020

BUY
$7.84 - $23.29 $13,876 - $41,223
1,770 New
1,770 $40,000
Q4 2019

Feb 14, 2020

SELL
$7.9 - $10.14 $34,997 - $44,920
-4,430 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$9.17 - $12.01 $41,540 - $54,405
-4,530 Reduced 50.56%
4,430 $42,000
Q3 2018

Nov 15, 2018

BUY
$14.85 - $16.35 $133,056 - $146,496
8,960 New
8,960 $134,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.